Surgical management of macular holes: Results using gas tamponade alone, or in combination with autologous platelet concentrate, or transforming growth factor β2

British Journal of Ophthalmology

Volumn 81, Issue 12, 1997, Pages 1073-1079

  Minihan, M ^a   Goggin, M ^a   Cleary, P E ^a  

^a University College Cork and INFANT Centre   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE CONCENTRATE; TRANSFORMING GROWTH FACTOR BETA2;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETINA MACULA HOLE; RETINA SURGERY; SURGICAL ANATOMY; VISUAL ACUITY; VITRECTOMY;

EID: 0030666384     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.81.12.1073     Document Type: Article

References (33)

1. The Eye Disease Case-Control Study Group. Risk factors for idiopathic macular holes. Am J Ophthalmol 1994; 118:754-61.
2. Gass JDM. Idiopathic macular hole; its early stages and pathogenesis. Arch Ophthalmol 1988;106:629-39.
3. Lewis H, Cowan GM, Straatsma BR. Apparent disappearance of a macular hole with development of an epiretinal membrane. Am J Ophthalmol 1986;102:172-5.
4. Schocket SS, Lakhanpal V, Miao XP Laser treatment of macular holes. Ophthalmology 1988;95:574-82.
5. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes: results of a pilot study. Arch Ophthalmol 1991;109:654-9.
6. Glaser BM, Michels RG, Kuppermann BD, Sjaarda RN, Pena RA. Transforming growth factor-beta 2 for the treatment of full-thickness macular holes; a prospective randomised study. Ophthalmology 1992;99:1162-72.
7. Liggett PE, Skolik DSA, Horio B, Saito Y, Alfaro V, Mieler W. Human autologous serum for the treatment of full-thickness macular holes. A preliminary study. Ophthalmology 1995;102:1071-6.
8. Gaudric A, Massin P, Paques M, Santiago PY, Guez JE, Le Gargasson JF, et al. Autologous platelet concentrate for the treatment of full-thickness macular holes. Graefes Arch Clin Exp Ophthalmol 1995;233:549-54.
9. Barrie T. Macular holes. (Editorial) Br J Ophthalmol 1995;79:511-2.
10. Fine SL. Vitreous surgery for macular hole in perspective: is there an indication? Arch Ophthalmol 1991;109:635-6.
11. Gass JDM. Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol 1995;119:752-9.
12. Lansing MB, Glaser BM, Liss H, Hanham A, Thompson JT, Sjaarda RN, et al. The effect of pars plana vitrectomy without epiretinal membrane peeling on full-thickness macular holes. Ophthalmology 1993;100:868-72.
13. Thompson JT, Glaser BM, Sjaarda RN, Murphy RP, Hanham A. Effects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor beta 2. Ophthalmology 1994;101:1195-200.
14. Steed DL, Gosler JB, Holloway GA, Malone JM, Bunt TJ, Webster MW. Randomised double-blind trial in treating chronic diabetic foot ulcers CT102 activated platelet supernatant, topical versus placebo. Diabetes Care 1992;15: 1598-604.
15. Korobelnik JF, Hannouche D, Belayachi N, Branger M, Guez JE, Hoang-Xuan T. Autologous platelet concentrate as an adjunct in macular hole healing. A pilot study. Ophthalmology 1996;103:590-4.
16. Smiddy WE, Glaser BM, Green WR, Concor TB, Roberts AB, Lucas R, et al. Transforming growth factor beta. A biologic chorioretinal glue. Arch Ophthalmol 1989;107:577-80.
17. Christmas NJ, Skolik SA, Howard MA, Saito Y, Barnstable CJ, Liggett PE. Treatment of retinal breaks with autologous serum in an experimental model. Ophthalmology 1995;102: 263-71.
18. Wendel RT, Patel AC, Kelly NE, Salzano TC, Wells JW, Novack GD. Vitreous surgery for macular holes. Ophthalmology 1993;100:1671-6.
19. Smiddy WE, Glaser BM, Thompson JT, Sjaarda RN, Flynn HW, Hanham A, et al. Transforming growth factor beta 2 significantly enhances the ability to flauen the rim of subretinal fluid surrounding macular holes. Preliminary results of a multicenter prospective randomised study. Retina 1993;13:296-301.
20. Polk TD, Smiddy WE, Flynn HW. Bilateral visual function after macular hole surgery. Ophthalmology 1996;103:422-6.
21. Yoshida A, Ishiko S, Akiba J. Radiating retinal folds detected by the scanning laser ophthalmoscope in idiopathic macular holes. Report at Club Jules Gonnin Meeting; September 1996.
22. Thompson JT, Smiddy WE, Williams GA. Comparison of recombinant TGF-B2 and placebo as an adjunctive agent for macular hole surgery. Ophthalmology 1995; 102(suppl): 91.
23. Ruby AJ, Williams DF, Grand MG, Thomas MA, Meredith TA, Boniuk I, et al. Pars plana vitrectomy for treatment of stage 2 macular holes. Arch Ophthalmol 1994;112:359-64.
24. Ryan EH, Gilbert HD. Results of surgical treatment of recent-onset full thickness macular holes. Arch Ophthalmol 1994;112:1545-53.
25. Ie D, Glaser BM, Thompson JT, Sjaarda RN, Gordon LW. Retreatment of full-thickness macular holes persisting after prior vitrectomy. A pilot study. Ophthalmology 1993;100: 1787-93.
26. Smiddy WE, Sjaarda RN, Glaser BM, Flynn HW, Thompson JT, Hanham A, et al. Reoperation after failed macular hole surgery. Retina 1996;16:13-18.
27. Thompson JT, Glaser BM, Sjaarda RN, Murphy RP. Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes. Am J Ophthalmol 1995; 119:48-54.
28. Park SS, Marcus DM, Duker JS, Pesavento RD, Topping TM, Frederick AR, et al. Posterior segment complications after vitrectomy for macular hole. Ophthalmology 1995;102: 775-81.
29. Stirpe M. Complications of removal of the posterior vitreous face during vitreous surgery. Presented at Club Jules Gonin Meeting, September 1996.
30. Bacon AS, Davison CR, Patel BC, Frazer DG, Ficker LA, Dart JKG. Infective endophthalmitis following vitreoretinal surgery. Eye 1993;7:529-34.
31. Melberg NS, Thomas MA. Visual field loss after pars plana vitrectomy with air/fluid exchange. Am J Ophthalmol 1995; 120:386-8.
32. Ezra E, Arden GB, Riordan-Eva P, Aylward GW, Gregor ZJ. Visual field loss following vitrectomy for stage 2 and 3 macular holes. Br J Ophthalmol 1996;80:519-25.
33. Prendergast SD, McCuen BW. Visual field loss after macular hole surgery Ophthalmology 1996;103:1069-77.